Detection of cerebral tauopathy in P301L mice using high-resolution large-field multifocal illumination fluorescence

Ruiqing Ni1,2, Zhenyue Chen1,3, Juan A Gerez4

  • 1University of Zurich & ETH Zurich, Institute for Biomedical Engineering, Department of Information Technology and Electrical Engineering, Wolfgang-Pauli-strasse 27 HIT E22.4, 8093, Zurich, Switzerland.

Insights

Researchers developed a new transcranial fluorescence microscopy technique to visualize tauopathy across the entire mouse cortex. This method offers a larger field-of-view for studying tau spreading and potential treatments.

Area of Science:

  • Neuroscience
  • Biomedical Imaging
  • Biochemistry

Background:

  • Current intravital microscopy for tauopathy has limitations in field-of-view and depth-of-focus.
  • Tauopathy, a hallmark of neurodegenerative diseases like Alzheimer's, requires advanced imaging techniques for effective study.

Purpose of the Study:

  • To develop and validate a novel transcranial fluorescence microscopy technique for large-scale tauopathy visualization.
  • To identify an optimal fluorescent ligand for in vivo tau imaging.

Main Methods:

  • Utilized large-field multifocal illumination (LMI) fluorescence microscopy.
  • Employed luminescent conjugated oligothiophenes, specifically the h-FTAA ligand, for tau detection.
  • Validated probe specificity and efficacy using P301L tauopathy mouse models and immunohistochemistry.

Main Results:

  • Demonstrated transcranial detection of tauopathy across the entire cortex of P301L mice.
  • Identified h-FTAA as an optimal fluorescent ligand for in vivo tau imaging, showing higher retention in tauopathy models.
  • Confirmed the specificity of h-FTAA for tau detection in P301L mice.

Conclusions:

  • The new LMI fluorescence microscopy platform enables whole-cortex visualization of tauopathy in vivo.
  • This technique is valuable for pre-clinical research on tau spreading, clearance mechanisms, and therapeutic interventions.
  • Facilitates longitudinal monitoring of tau-targeting treatments in neurodegenerative disease models.

Related Concept Videos